Increased oxidative stress and severe arterial remodeling induced by permanent high-flow challenge in experimental pulmonary hypertension

Respiratory Research

Volumn 12, Issue , 2011, Pages

  Dorfmüller, Peter ^a,b,c,d   Chaumais, Marie Camille ^a,c   Giannakouli, Maria ^c   Durand Gasselin, Ingrid ^b   Raymond, Nicolas ^c,d   Fadel, Elie ^a,c   Mercier, Olaf ^a,c   Charlotte, Frédéric ^e   Montani, David ^a,b,c   Simonneau, Gérald ^a,b,c   Humbert, Marc ^a,b,c   Perros, Frédéric ^a,c  

^a UNIVERSITÉ PARIS SACLAY   (France)

^b HÔPITAL ANTOINE BÉCLÈRE   (France)

^c Universite Paris Sud   (France)

^d CENTRE CHIRURGICAL MARIE LANNELONGUE   (France)

^e PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

3 NITROTYROSINE; ACTIN; CD68 ANTIGEN; CHEMOKINE RECEPTOR CXCR4; FASCIN; FRACTALKINE; GLUTATHIONE PEROXIDASE 1; INTERLEUKIN 6; MALONALDEHYDE; MONOCROTALINE; OX62 PROTEIN; RANTES; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE 4; SUPEROXIDE DISMUTASE; UNCLASSIFIED DRUG;

AIRWAY REMODELING; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERIOLE; ARTICLE; CELL INFILTRATION; CELL PROLIFERATION; CONTROLLED STUDY; DISEASE SEVERITY; ENDOTHELIUM CELL; HISTOLOGY; INFLAMMATORY CELL; LEUKOCYTE; LUNG BLOOD FLOW; LUNG HEMODYNAMICS; LUNG PARENCHYMA; LUNG RESECTION; MALE; MAST CELL; NONHUMAN; OXIDATIVE STRESS; POLYMERASE CHAIN REACTION; PULMONARY HYPERTENSION; RAT; SMOOTH MUSCLE FIBER;

EID: 80052572916     PISSN: 14659921     EISSN: 1465993X     Source Type: Journal    
DOI: 10.1186/1465-9921-12-119     Document Type: Article

References (67)

1. Simonneau G, Robbins IM, Beghetti M, Channick RN, Delcroix M, Denton CP, Elliott CG, Gaine SP, Gladwin MT, Jing ZC, et al. Updated Clinical Classification of Pulmonary Hypertension. Journal of the American College of Cardiology 2009, 54:S43-S54. 10.1016/j.jacc.2009.04.012, 19555858.
2. Deng Z, Morse J, Slager S, Cuervo N, Moore K, Venetos G, Kalachikov S, Cayanis E, Fischer S, Barst R, et al. Familial primary pulmonary hypertension (gene PPH1) is caused by mutations in the bone morphogenetic protein receptor-II gene. Am J Hum Genet 2000, 67:737-744. 10.1086/303059, 1287532, 10903931.
3. Trembath R, Thomson J, Machado R, Morgan N, Atkinson C, Winship I, Simonneau G, Galie N, Loyd J, Humbert M, et al. Clinical and molecular genetic features of pulmonary hypertension in patients with hereditary hemorrhagic telangiectasia. N Engl J Med 2001, 345:325-334. 10.1056/NEJM200108023450503, 11484689.
4. Bonnet S, Michelakis E, Porter C, Andrade-Navarro M, Thébaud B, Haromy A, Harry G, Moudgil R, McMurtry M, Weir E, Archer S. An abnormal mitochondrial-hypoxia inducible factor-1 alpha-Kv channel pathway disrupts oxygen sensing and triggers pulmonary arterial hypertension in fawn hooded rats: similarities to human pulmonary arterial hypertension. Circulation 2006, 113:2630-2641. 10.1161/CIRCULATIONAHA.105.609008, 16735674.
5. Cool C, Kennedy D, Voelkel N, Tuder R. Pathogenesis and evolution of plexiform lesions in pulmonary hypertension associated with scleroderma and human immunodeficiency virus infection. Hum Pathol 1997, 28:434-442. 10.1016/S0046-8177(97)90032-0, 9104943.
6. Tuder R, Groves B, Badesch D, Voelkel N. Exuberant endothelial cell growth and elements of inflammation are present in plexiform lesions of pulmonary hypertension. Am J Pathol 1994, 144:275-285. 1887146, 7508683.
7. Dorfmüller P, Humbert M, Perros F, Sanchez O, Simonneau G, Müller KM, Capron F. Fibrous remodeling of the pulmonary venous system in pulmonary arterial hypertension associated with connective tissue diseases. Hum Pathol 2007, 38:893-902. 10.1016/j.humpath.2006.11.022, 17376507.
8. Perros F, Dorfmüller P, Souza R, Durand-Gasselin I, Mussot S, Mazmanian M, Hervé P, Emilie D, Simonneau G, Humbert M. Dendritic cell recruitment in lesions of human and experimental pulmonary hypertension. Eur Respir J 2007, 29:462-468. 10.1183/09031936.00094706, 17107989.
9. Balabanian K, Foussat A, Dorfmüller P, Durand-Gasselin I, Capel F, Bouchet-Delbos L, Portier A, Marfaing-Koka A, Krzysiek R, Rimaniol A, et al. CX(3)C chemokine fractalkine in pulmonary arterial hypertension. Am J Respir Crit Care Med 2002, 165:1419-1425. 10.1164/rccm.2106007, 12016106.
10. Dorfmuller P, Zarka V, Durand-Gasselin I, Monti G, Balabanian K, Garcia G, Capron F, Coulomb-Lhermine A, Marfaing-Koka A, Simonneau G, et al. Chemokine RANTES in severe pulmonary arterial hypertension. American Journal of Respiratory and Critical Care Medicine 2002, 165:534-539.
11. Humbert M, Monti G, Brenot F, Sitbon O, Portier A, Grangeot-Keros L, Duroux P, Galanaud P, Simonneau G, Emilie D. Increased interleukin-1 and interleukin-6 serum concentrations in severe primary pulmonary hypertension. Am J Respir Crit Care Med 1995, 151:1628-1631.
12. Perros F, Montani D, Dorfmüller P, Durand-Gasselin I, Tcherakian C, Le Pavec J, Mazmanian M, Fadel E, Mussot S, Mercier O, et al. Platelet-derived growth factor expression and function in idiopathic pulmonary arterial hypertension. Am J Respir Crit Care Med 2008, 178:81-88. 10.1164/rccm.200707-1037OC, 18420966.
13. Satoh K, Nigro P, Matoba T, O'Dell M, Cui Z, Shi X, Mohan A, Yan C, Abe J, Illig K, Berk B. Cyclophilin A enhances vascular oxidative stress and the development of angiotensin II-induced aortic aneurysms. Nat Med 2009, 15:649-656. 10.1038/nm.1958, 2704983, 19430489.
14. Beckman J, Koppenol W. Nitric oxide, superoxide, and peroxynitrite: the good, the bad, and ugly. Am J Physiol 1996, 271:C1424-1437.
15. Irani K. Oxidant signaling in vascular cell growth, death, and survival: a review of the roles of reactive oxygen species in smooth muscle and endothelial cell mitogenic and apoptotic signaling. Circ Res 2000, 87:179-183.
16. Satoh K, Matoba T, Suzuki J, O'Dell M, Nigro P, Cui Z, Mohan A, Pan S, Li L, Jin Z, et al. Cyclophilin A mediates vascular remodeling by promoting inflammation and vascular smooth muscle cell proliferation. Circulation 2008, 117:3088-3098. 10.1161/CIRCULATIONAHA.107.756106, 2775430, 18541741.
17. Millonig G, Niederegger H, Rabl W, Hochleitner B, Hoefer D, Romani N, Wick G. Network of vascular-associated dendritic cells in intima of healthy young individuals. Arterioscler Thromb Vasc Biol 2001, 21:503-508. 10.1161/01.ATV.21.4.503, 11304464.
18. Silacci P, Desgeorges A, Mazzolai L, Chambaz C, Hayoz D. Flow pulsatility is a critical determinant of oxidative stress in endothelial cells. Hypertension 2001, 38:1162-1166. 10.1161/hy1101.095993, 11711515.
19. Zhu WG, Li S, Lin LQ, Yan H, Fu T, Zhu JH. Vascular oxidative stress increases dendritic cell adhesion and transmigration induced by homocysteine. Cell Immunol 2009, 254:110-116. 10.1016/j.cellimm.2008.08.001, 18809175.
20. Bowers R, Cool C, Murphy R, Tuder R, Hopken M, Flores S, Voelkel N. Oxidative stress in severe pulmonary hypertension. Am J Respir Crit Care Med 2004, 169:764-769. 10.1164/rccm.200301-147OC, 14701708.
21. Okada K, Tanaka Y, Bernstein M, Zhang W, Patterson G, Botney M. Pulmonary hemodynamics modify the rat pulmonary artery response to injury. A neointimal model of pulmonary hypertension. Am J Pathol 1997, 151:1019-1025. 1858047, 9327735.
22. Juremalm M, Hjertson M, Olsson N, Harvima I, Nilsson K, Nilsson G. The chemokine receptor CXCR4 is expressed within the mast cell lineage and its ligand stromal cell-derived factor-1 alpha acts as a mast cell chemotaxin. Eur J Immunol 2000, 30:3614-3622. 10.1002/1521-4141(200012)30:12<3614::AID-IMMU3614>3.0.CO;2-B, 11169404.
23. Godot V, Arock M, Garcia G, Capel F, Flys C, Dy M, Emilie D, Humbert M. H4 histamine receptor mediates optimal migration of mast cell precursors to CXCL12. J Allergy Clin Immunol 2007, 120:827-834. 10.1016/j.jaci.2007.05.046, 17681365.
24. Montani D, Perros F, Gambaryan N, Girerd B, Dorfmuller P, Price LC, Huertas A, Hammad H, Lambrecht B, Simonneau G, et al. C-Kit Positive Cells Accumulate in Remodeled Vessels of Idiopathic Pulmonary Arterial Hypertension. Am J Respir Crit Care Med 2011,
25. Heath D, Yacoub M. Lung mast cells in plexogenic pulmonary arteriopathy. J Clin Pathol 1991, 44:1003-1006. 10.1136/jcp.44.12.1003, 494968, 1791199.
26. Dahal BK, Kosanovic D, Kaulen C, Cornitescu T, Savai R, Hoffmann J, Reiss I, Ghofrani HA, Weissmann N, Kuebler WM, et al. Involvement of mast cells in monocrotaline-induced pulmonary hypertension in rats. Respir Res 2011, 12:60. 10.1186/1465-9921-12-60, 3104382, 21535881.
27. Hoffmann J, Yin J, Kukucka M, Yin N, Saarikko I, Sterner-Kock A, Fujii H, Leong-Poi H, Kuppe H, Schermuly RT, Kuebler WM. Mast cells promote lung vascular remodelling in pulmonary hypertension. Eur Respir J 2011, 37:1400-1410. 10.1183/09031936.00043310, 21148228.
28. De Keulenaer G, Chappell D, Ishizaka N, Nerem R, Alexander R, Griendling K. Oscillatory and steady laminar shear stress differentially affect human endothelial redox state: role of a superoxide-producing NADH oxidase. Circ Res 1998, 82:1094-1101.
29. Ravensbergen J, Ravensbergen J, Krijger J, Hillen B, Hoogstraten H. Localizing role of hemodynamics in atherosclerosis in several human vertebrobasilar junction geometries. Arterioscler Thromb Vasc Biol 1998, 18:708-716. 10.1161/01.ATV.18.5.708, 9598828.
30. Wagner A, Kautz O, Fricke K, Zerr-Fouineau M, Demicheva E, Güldenzoph B, Bermejo J, Korff T, Hecker M. Upregulation of glutathione peroxidase offsets stretch-induced proatherogenic gene expression in human endothelial cells. Arterioscler Thromb Vasc Biol 2009, 29:1894-1901. 10.1161/ATVBAHA.109.194738, 19729606.
31. Ali F, Zakkar M, Karu K, Lidington E, Hamdulay S, Boyle J, Zloh M, Bauer A, Haskard D, Evans P, Mason J. Induction of the cytoprotective enzyme heme oxygenase-1 by statins is enhanced in vascular endothelium exposed to laminar shear stress and impaired by disturbed flow. J Biol Chem 2009, 284:18882-18892. 10.1074/jbc.M109.009886, 2707208, 19457866.
32. Porteri E, Rodella L, Rezzani R, Rizzoni D, Paiardi S, de Ciuceis C, Boari G, Foglio E, Favero G, Rizzardi N, et al. Role of heme oxygenase in modulating endothelial function in mesenteric small resistance arteries of spontaneously hypertensive rats. Clin Exp Hypertens 2009, 31:560-571. 10.3109/10641960902927978, 19886854.
33. Yu H, Hwang T, Yen C, Lau Y. Resveratrol prevents endothelial dysfunction and aortic superoxide production after trauma hemorrhage through estrogen receptor-dependent hemeoxygenase-1 pathway. Crit Care Med 2010, 38:1147-1154. 10.1097/CCM.0b013e3181cd124e, 20081535.
34. Loboda A, Stachurska A, Florczyk U, Rudnicka D, Jazwa A, Wegrzyn J, Kozakowska M, Stalinska K, Poellinger L, Levonen AL, et al. HIF-1 induction attenuates Nrf2-dependent IL-8 expression in human endothelial cells. Antioxid Redox Signal 2009, 11:1501-1517. 10.1089/ars.2008.2211, 19254160.
35. Semenza GL. Involvement of hypoxia-inducible factor 1 in pulmonary pathophysiology. Chest 2005, 128:592S-594S.
36. Zhang Q, Bellotto DJ, Ravikumar P, Moe OW, Hogg RT, Hogg DC, Estrera AS, Johnson RL, Hsia CC. Postpneumonectomy lung expansion elicits hypoxia-inducible factor-1 alpha signaling. Am J Physiol Lung Cell Mol Physiol 2007, 293:L497-504. 10.1152/ajplung.00393.2006, 17513452.
37. Podlutsky A, Ballabh P, Csiszar A. Oxidative stress and endothelial dysfunction in pulmonary arteries of aged rats. Am J Physiol Heart Circ Physiol 2010, 298:H346-351. 10.1152/ajpheart.00972.2009, 19966046.
38. Wind S, Beuerlein K, Armitage M, Taye A, Kumar A, Janowitz D, Neff C, Shah A, Wingler K, Schmidt H. Oxidative stress and endothelial dysfunction in aortas of aged spontaneously hypertensive rats by NOX1/2 is reversed by NADPH oxidase inhibition. Hypertension 2010, 56:490-497. 10.1161/HYPERTENSIONAHA.109.149187, 20606112.
39. Davie N, Gerasimovskaya E, Hofmeister S, Richman A, Jones P, Reeves J, Stenmark K. Pulmonary artery adventitial fibroblasts cooperate with vasa vasorum endothelial cells to regulate vasa vasorum neovascularization: a process mediated by hypoxia and endothelin-1. Am J Pathol 2006, 168:1793-1807. 10.2353/ajpath.2006.050754, 1606613, 16723696.
40. Li S, Tabar S, Malec V, Eul B, Klepetko W, Weissmann N, Grimminger F, Seeger W, Rose F, Hänze J. NOX4 regulates ROS levels under normoxic and hypoxic conditions, triggers proliferation, and inhibits apoptosis in pulmonary artery adventitial fibroblasts. Antioxid Redox Signal 2008, 10:1687-1698. 10.1089/ars.2008.2035, 18593227.
41. Ismail S, Sturrock A, Wu P, Cahill B, Norman K, Huecksteadt T, Sanders K, Kennedy T, Hoidal J. NOX4 mediates hypoxia-induced proliferation of human pulmonary artery smooth muscle cells: the role of autocrine production of transforming growth factor-{beta}1 and insulin-like growth factor binding protein-3. Am J Physiol Lung Cell Mol Physiol 2009, 296:L489-499. 10.1152/ajplung.90488.2008, 2660216, 19036873.
42. Esterbauer H, Gebicki J, Puhl H, Jürgens G. The role of lipid peroxidation and antioxidants in oxidative modification of LDL. Free Radic Biol Med 1992, 13:341-390. 10.1016/0891-5849(92)90181-F, 1398217.
43. Beal M. Oxidatively modified proteins in aging and disease. Free Radic Biol Med 2002, 32:797-803. 10.1016/S0891-5849(02)00780-3, 11978481.
44. Cadet J, Bellon S, Berger M, Bourdat A, Douki T, Duarte V, Frelon S, Gasparutto D, Muller E, Ravanat J, Sauvaigo S. Recent aspects of oxidative DNA damage: guanine lesions, measurement and substrate specificity of DNA repair glycosylases. Biol Chem 2002, 383:933-943. 10.1515/BC.2002.100, 12222683.
45. De Miguel C, Guo C, Lund H, Feng D, Mattson DL. Infiltrating T lymphocytes in the kidney increase oxidative stress and participate in the development of hypertension and renal disease. Am J Physiol Renal Physiol 2010,
46. Dorfmuller P, Perros F, Balabanian K, Humbert M. Inflammation in pulmonary arterial hypertension. European Respiratory Journal 2003, 22:358-363. 10.1183/09031936.03.00038903, 12952274.
47. Furuya Y, Satoh T, Kuwana M. Interleukin-6 as a potential therapeutic target for pulmonary arterial hypertension. Int J Rheumatol 2010, 2010:720305. 2958514, 20981316.
48. Steiner MK, Syrkina OL, Kolliputi N, Mark EJ, Hales CA, Waxman AB. Interleukin-6 overexpression induces pulmonary hypertension. Circ Res 2009, 104:236-244. 228p following 244, 10.1161/CIRCRESAHA.108.182014, 19074475.
49. Speyer CL, Gao H, Rancilio NJ, Neff TA, Huffnagle GB, Sarma JV, Ward PA. Novel chemokine responsiveness and mobilization of neutrophils during sepsis. Am J Pathol 2004, 165:2187-2196. 10.1016/S0002-9440(10)63268-3, 1618724, 15579460.
50. Oppenheim JJ, Zachariae CO, Mukaida N, Matsushima K. Properties of the novel proinflammatory supergene "intercrine" cytokine family. Annu Rev Immunol 1991, 9:617-648. 10.1146/annurev.iy.09.040191.003153, 1910690.
51. Zhang Y, Lin JX, Vilcek J. Synthesis of interleukin 6 (interferon-beta 2/B cell stimulatory factor 2) in human fibroblasts is triggered by an increase in intracellular cyclic AMP. J Biol Chem 1988, 263:6177-6182.
52. Voelkel NF, Tuder RM, Bridges J, Arend WP. Interleukin-1 receptor antagonist treatment reduces pulmonary hypertension generated in rats by monocrotaline. Am J Respir Cell Mol Biol 1994, 11:664-675.
53. El-Haroun H, Clarke DL, Deacon K, Bradbury D, Clayton A, Sutcliffe A, Knox AJ. IL-1 beta, BK, and TGF-beta1 attenuate PGI2-mediated cAMP formation in human pulmonary artery smooth muscle cells by multiple mechanisms involving p38 MAP kinase and PKA. Am J Physiol Lung Cell Mol Physiol 2008, 294:L553-562.
54. Fischer FR, Luo Y, Luo M, Santambrogio L, Dorf ME. RANTES-induced chemokine cascade in dendritic cells. J Immunol 2001, 167:1637-1643.
55. Long L, Crosby A, Yang X, Southwood M, Upton PD, Kim DK, Morrell NW. Altered bone morphogenetic protein and transforming growth factor-beta signaling in rat models of pulmonary hypertension: potential for activin receptor-like kinase-5 inhibition in prevention and progression of disease. Circulation 2009, 119:566-576. 10.1161/CIRCULATIONAHA.108.821504, 19153267.
56. Tanaka Y, Schuster D, Davis E, Patterson G, Botney M. The role of vascular injury and hemodynamics in rat pulmonary artery remodeling. J Clin Invest 1996, 98:434-442. 10.1172/JCI118809, 507447, 8755654.
57. Homma N, Nagaoka T, Karoor V, Imamura M, Taraseviciene-Stewart L, Walker L, Fagan K, McMurtry I, Oka M. Involvement of RhoA/Rho kinase signaling in protection against monocrotaline-induced pulmonary hypertension in pneumonectomized rats by dehydroepiandrosterone. Am J Physiol Lung Cell Mol Physiol 2008, 295:L71-78. 10.1152/ajplung.90251.2008, 2494797, 18469113.
58. Le Cras T, Fernandez L, Pastura P, Laubach V. Vascular growth and remodeling in compensatory lung growth following right lobectomy. J Appl Physiol 2005, 98:1140-1148.
59. Banchereau J, Steinman R. Dendritic cells and the control of immunity. Nature 1998, 392:245-252. 10.1038/32588, 9521319.
60. Tan J, O'Neill H. Maturation requirements for dendritic cells in T cell stimulation leading to tolerance versus immunity. J Leukoc Biol 2005, 78:319-324. 10.1189/jlb.1104664, 15809288.
61. Bobryshev Y. Dendritic cells in atherosclerosis: current status of the problem and clinical relevance. Eur Heart J 2005, 26:1700-1704. 10.1093/eurheartj/ehi282, 15855191.
62. Rivollier A, Perrin-Cocon L, Luche S, Diemer H, Strub J, Hanau D, van Dorsselaer A, Lotteau V, Rabourdin-Combe C, Rabilloud T, Servet-Delprat C. High expression of antioxidant proteins in dendritic cells: possible implications in atherosclerosis. Mol Cell Proteomics 2006, 5:726-736.
63. Heier I, Malmström K, Sajantila A, Lohi J, Mäkelä M, Jahnsen FL. Characterisation of bronchus-associated lymphoid tissue and antigen-presenting cells in central airway mucosa of children. Thorax 2010,
64. Rangel-Moreno J, Hartson L, Navarro C, Gaxiola M, Selman M, Randall TD. Inducible bronchus-associated lymphoid tissue (iBALT) in patients with pulmonary complications of rheumatoid arthritis. J Clin Invest 2006, 116:3183-3194. 10.1172/JCI28756, 1678820, 17143328.
65. Frid M, Brunetti J, Burke D, Carpenter T, Davie N, Reeves J, Roedersheimer M, van Rooijen N, Stenmark K. Hypoxia-induced pulmonary vascular remodeling requires recruitment of circulating mesenchymal precursors of a monocyte/macrophage lineage. Am J Pathol 2006, 168:659-669. 10.2353/ajpath.2006.050599, 1606508, 16436679.
66. Burke D, Frid M, Kunrath C, Karoor V, Anwar A, Wagner B, Strassheim D, Stenmark K. Sustained hypoxia promotes the development of a pulmonary artery-specific chronic inflammatory microenvironment. Am J Physiol Lung Cell Mol Physiol 2009, 297:L238-250. 10.1152/ajplung.90591.2008, 2742800, 19465514.
67. Mor-Vaknin N, Punturieri A, Sitwala K, Markovitz DM. Vimentin is secreted by activated macrophages. Nat Cell Biol 2003, 5:59-63. 10.1038/ncb898, 12483219.